We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04138927
Brief Title: A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

First Submitted : October 23, 2019
First Submitted that Met QC Criteria : October 23, 2019
First Posted : October 25, 2019

Last Update Submitted that Met QC Criteria : March 2, 2022
Last Update Posted : March 17, 2022